Featured Post

Latest Gold News

Fed doves supporting gold Stronger rand crushing South African miners Economic power could shift further East with Hong Kong gold exch...

Friday, December 30, 2011

Human Genome Sciences (HGSI) Ratings, Price Targets

Updates on Human Genome Sciences (NASDAQ: HGSI) ratings and price targets.

Human Genome Sciences (NASDAQ: HGSI) had its “Neutral” rating reiterated by Goldman Sachs (NYSE: GS).

Citigroup (NYSE: C) lowered their price target on Human Genome Sciences to $8.00.

Barclays Capital (NYSE: BCS) initiated coverage on Human Genome Sciences. They placed an “Equal Weight” rating and a price target of $8.00 on the company.

Stifel Nicolaus lowered their price target on Human Genome Sciences (NASDAQ: HGSI) from $17.00 to $15.00. They have a “Buy” rating on the company.

Summer Street has a price target of $23.00 on Human Genome Sciences.

No comments: